IRIS
BELLAN, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.570
EU - Europa 9.668
AS - Asia 4.461
SA - Sud America 700
AF - Africa 106
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.433
GB - Regno Unito 2.490
RU - Federazione Russa 2.003
CN - Cina 1.770
SG - Singapore 1.357
IE - Irlanda 1.229
IT - Italia 988
DE - Germania 713
SE - Svezia 655
BR - Brasile 627
UA - Ucraina 626
FR - Francia 398
HK - Hong Kong 394
KR - Corea 261
FI - Finlandia 258
VN - Vietnam 236
IN - India 130
TR - Turchia 96
CA - Canada 85
ES - Italia 58
PL - Polonia 54
BE - Belgio 47
BD - Bangladesh 44
NL - Olanda 37
AT - Austria 35
AR - Argentina 34
MX - Messico 33
CI - Costa d'Avorio 29
JP - Giappone 28
IQ - Iraq 26
ZA - Sudafrica 26
ID - Indonesia 19
SA - Arabia Saudita 16
EC - Ecuador 15
KE - Kenya 15
CZ - Repubblica Ceca 14
AU - Australia 13
MA - Marocco 12
PK - Pakistan 12
IL - Israele 10
CH - Svizzera 9
RO - Romania 9
UZ - Uzbekistan 9
GR - Grecia 8
IR - Iran 8
EU - Europa 7
PA - Panama 7
UG - Uganda 7
AZ - Azerbaigian 6
CL - Cile 6
CO - Colombia 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DO - Repubblica Dominicana 5
NP - Nepal 5
EG - Egitto 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PE - Perù 4
VE - Venezuela 4
AM - Armenia 3
EE - Estonia 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MY - Malesia 2
PS - Palestinian Territory 2
PW - Palau 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LU - Lussemburgo 1
MK - Macedonia 1
NE - Niger 1
NG - Nigeria 1
Totale 25.525
Salva come PNG Salva come JPEG
Città #
Southend 2.290
Dallas 1.224
Dublin 1.191
Fairfield 1.037
Singapore 790
Ashburn 778
Houston 709
Chandler 640
Moscow 582
Santa Clara 557
Jacksonville 534
Beijing 513
Woodbridge 496
Siena 396
Wilmington 392
Hong Kong 390
Seattle 354
Ann Arbor 346
Cambridge 312
Seoul 259
Hefei 258
Princeton 241
Menlo Park 216
New York 194
Nanjing 185
Los Angeles 159
Munich 140
Boardman 86
Helsinki 80
Dong Ket 77
Dearborn 76
Nanchang 74
San Mateo 72
Buffalo 70
Florence 70
Ho Chi Minh City 68
Shanghai 68
Izmir 67
Milan 66
The Dalles 65
São Paulo 62
San Diego 60
Turku 55
Brussels 47
Málaga 44
Warsaw 44
Chicago 40
Columbus 38
Düsseldorf 37
Rome 37
Bengaluru 36
London 36
Shenyang 36
Tianjin 34
Council Bluffs 33
Montreal 33
Fremont 31
Redondo Beach 30
Abidjan 29
Lappeenranta 29
Hebei 28
Denver 27
Jiaxing 27
San Francisco 27
Changsha 26
Brooklyn 24
Kunming 24
Toronto 24
Atlanta 23
Sezze 23
Tokyo 23
Hanoi 21
Belo Horizonte 20
Guangzhou 20
Orem 20
Frankfurt am Main 19
Vienna 19
Falls Church 18
Jinan 18
Phoenix 18
Stockholm 18
Johannesburg 17
Norwalk 17
Nuremberg 17
Rio de Janeiro 16
Scarperia 16
Zhengzhou 16
Chennai 15
Poplar 15
Washington 15
Mexico City 14
Venezia 14
Boston 13
Hangzhou 13
Manchester 13
Philadelphia 13
Ankara 12
Naples 12
Ningbo 12
Paris 12
Totale 17.652
Salva come PNG Salva come JPEG
Nome #
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach 546
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 363
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 326
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 326
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression 312
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 307
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 305
Frequent Traces of EBV Infection in Hodgkin and non-Hodgkin Lymphomas Classified as EBV-negative by Routine Methods: Expanding the Landscape of EBV-related Lymphomas 303
Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature 298
Analisi del riarrangiamento e delle mutazioni del gene VH delle immunoglobuline nelle cellule B monocitoidi M-IRTA-1 positive. 296
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 295
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 291
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity 289
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 284
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 284
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. 282
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 281
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 279
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 267
Alteration of microRNAs regulated by c_Myc in Burkitt lymphoma 258
Burkitt lymphoma versus diffuse large B-cell lymphoma: A practical approach 249
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1 239
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 235
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 234
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas 232
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 230
EBV reactivation influences clonal evolution in HHV8 related lymphoprolipherative disorders? 230
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 227
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 226
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? 223
Burkitt’s lymphoma: new insights into molecular pathogenesis 223
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas 223
Analysis of rearrangement and Vh gene mutations and correlation with the expression of M-IRTA 1 in monocytoid B cells of toxoplasmic lymphadenitis. 214
Identification of single-nucleotide variants by high-throughput RNA sequencing in endemic Burkitt Lymphoma 214
Activation of MyoD-dependent transcription by cdk9/cyclin T2 212
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 212
Gene expression analysis uncovers similarty and differences among Burkitt lymphoma subtypes 210
Anaplastic large cell lymphomas and Hodgkin's disease: distinctive growth features and expression of p34cdc2 /cyclin B-1 209
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1 208
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. 207
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 203
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis 201
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 201
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 200
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 196
Immunoglobulin gene rearrangement analysis in composite Hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? 195
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. 191
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 191
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 189
Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature 187
Altered expression of miRNAs in c-Myc negative Burkitt lymphoma cases 182
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation 182
Oct-4 is highly expressed in stem/ progenitor cells and in primordial follicles of the fetal human ovary 182
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 181
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 181
Cell growth and death in malignant lymphomas. A quantitative analysis. 177
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection 175
Role of EBV in microRNA dysregulation in Burkitt lymphoma 175
Analysis of primary cilium expression and hedgehog pathway activation in mesothelioma throws back its complex biology 174
Tumor-Suppressor Genes as Diagnostic Tools 173
Cell kinetics and cell cycle regulation in lymphomas. 172
DNMT over-expression based on microRNA modulation in HIV-related aggressive B-cell lymphomas 172
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations 171
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo 171
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 170
P53 mutation in breast cancer, correlation with cell kinetics and cell of origin 169
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis 168
The XLMR gene ACSL4 plays a role in dendritic spine architecture 168
Pseudolymphoma of the kidney associated with high-grade bladder urothelial carcinoma 166
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 166
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis 164
Physical interaction between pRb and cdk9/cyclin T2 complex 164
null 164
Retinoblastoma gene family expression in lymphoid tissues 163
Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. 163
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms 162
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes 162
null 161
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 161
Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation 160
null 160
Are periodontitis and psoriasis associated? A pre-clinical murine model 156
MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt lymphoma cases 155
P53 mutation in breast cancer correlation with cell kinetics and cell of origin 155
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 155
Pathologic aspects of AIDS malignancies 152
Predictive prognostic factors of surgically treated intra-pulmonary mettstases from colorectal carcinomas: a 30 years retrospective analysis 152
The interaction between HIV-1 Tat and pRb2/p130: a possibile mechanisms in the pathogenesis of AIDS-related neoplasms. 151
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 151
Expression of p34(cdc2) and cyclin B-1 in Hodgkin's disease and anaplastic large cell lymphomas 147
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma (Cell Death & Disease, (2020), 11, 9, (748), 10.1038/s41419-020-02940-w) 145
TAVR and Dialysis Are a Challenging Combination. A Case Report and Systematic Review of Literature 145
Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature. 143
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 142
Lacunar and reed-sternberg-like cells in follicular lymphomas are clonally related to the centrocytic and centroblastic cells as demonstrated by laser capture microdissection 142
Novel Genomic Alterations in MCL1 and ARID1A Identified in Pediatric Burkitt Lymphoma Using Targeted High-Throughput Sequencing 142
Gene expression analysis identifies novel RBL2/P130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors 142
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 142
Cinetica e ciclo cellulare nei linfomi maligni: implicazioni terapeutiche e prognostiche. 140
Mesothelioma malignancy and the microenvironment: Molecular mechanisms 140
Totale 20.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.722 0 0 0 0 0 317 120 381 298 214 193 199
2021/20221.819 118 210 112 204 103 65 86 127 74 193 140 387
2022/20232.448 145 211 338 336 243 477 50 214 236 66 80 52
2023/20241.910 77 48 194 69 58 576 627 27 30 55 23 126
2024/20254.006 98 217 383 206 559 213 86 222 336 161 437 1.088
2025/20266.221 739 1.297 1.034 1.190 1.880 81 0 0 0 0 0 0
Totale 25.808